Company Filing History:
Years Active: 2016
Title: Frederic St-Jean: Innovator in Pharmaceutical Chemistry
Introduction
Frederic St-Jean is a notable inventor based in San Francisco, CA, recognized for his contributions to pharmaceutical chemistry. He holds two patents that reflect his innovative work in the field of drug development. His expertise has made a significant impact on the industry, particularly in the area of PI3K inhibitors.
Latest Patents
Frederic's latest patents include the development of crystalline polymorphs of a specific compound, 2-(4-(2-(1-(isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide, along with methods of production and pharmaceutical uses thereof. This invention relates to the processes of preparing and utilizing GDC-0032, also known as taselisib. Additionally, he has developed a process for making benzoxazepin compounds, which are crucial in the preparation of PI3K inhibitors.
Career Highlights
Frederic has worked with prominent companies in the pharmaceutical sector, including Genentech, Inc. and Green Tech Corporation. His experience in these organizations has allowed him to hone his skills and contribute to significant advancements in drug development.
Collaborations
Frederic has collaborated with talented individuals such as Travis Remarchuk and Jeffrey Stults, enhancing his work through shared expertise and innovative ideas.
Conclusion
Frederic St-Jean's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in drug development and therapeutic applications.